Veeva (VEEV) Introduces MuleSoft Connector For Vault Platform
Zacks Investment Research | Aug 22, 2019 09:12PM ET
Veeva Systems Inc. (NYSE:VEEV) recently announced the availability of the MuleSoft Connector for its flagship Vault platform. Notably, MuleSoft, a Salesforce (NYSE:CRM) company, is working with Veeva to make it faster and easier for healthcare companies to connect Veeva Vault applications with other enterprise systems. The latest move expands offerings for Veeva and Salesforce’s joint customers.
Additionally, it fortifies Veeva’s foothold in the healthcare IT (“HCIT”) space.
For investors’ notice, the MuleSoft Connector lets customers easily integrate Veeva Vault platform to third-party vendors using connector operations in Mule Flow. The MuleSoft Connector for Veeva Vault is developed and supported by MuleSoft and technically certified by both MuleSoft and Veeva to drive joint customer success.
Into Veeva Vault
Veeva Vault is a cloud-based content management platform that offers a suite of applications to help healthcare companies increase business agility. It not only manages regulated documents but also tracks critical information ranging from product development to commercialization.
Notably, the Veeva Vault suite comprises a large spectrum of services like Veeva Vault Submissions, Vault RIM, Vault PromoMats, Veeva CRM, Veeva Network and VeevaOpenData.
It is encouraging to note that in recent times, Veeva’s Vault platform has seen positive developments.
For instance, Early Access Care Limited recently selected Veeva Vault CDMS (Veeva Vault Clinical Data Management System) to provide electronic data capture, coding and data cleaning for their upcoming expanded access study.
Earlier this month, Veeva announced that Vault Safety AI, a new AI application, offers the first integrated suite of cloud applications on a common platform to manage the end-to-end drug safety lifecycle.
Last month, Alcon, a global medical device company, chose Veeva Vault CDMS as its enterprise clinical data management system for electronic data capture.
Additionally, Celltrion, a South Korean biopharmaceutical company, implemented Veeva Vault eTMF (trial master file) to improve oversight across its trial master file processes and achieve greater compliance. (Read More: .
Intuitive Surgical’s long-term earnings growth rate is estimated at 13.3%.
Baxter’s long-term earnings growth rate is projected at 12.8%.
Wall Street’s Next Amazon (NASDAQ:AMZN)
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Get The News You Want
Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.